BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Zalicus Pharmaceuticals Ltd. 

301 – 2389 Health Sciences Mall

Vancouver  British Columbia  V6T 1Z3  Canada
Phone: 604-909-2530 Fax: 604-909-2538


SEARCH JOBS










 Company News
CombinatoRx, Incorporated (CRXX) and Neuromed Pharmaceuticals Close Merger 12/22/2009 8:54:58 AM    More...
Stockholders of CombinatoRx, Incorporated (CRXX) and Neuromed Pharmaceuticals Vote for Merger 12/18/2009 11:56:01 AM    More...
FDA Extends NDA Review for Neuromed Pharmaceuticals's Exalgo(TM) Extended-Release Tablets 11/20/2009 8:31:56 AM    More...
CombinatoRx, Incorporated (CRXX) And Neuromed Pharmaceuticals Receive FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets 11/16/2009 9:40:13 AM    More...
CombinatoRx, Incorporated (CRXX) and Neuromed Pharmaceuticals Announce Posting of Briefing Documents for FDA Advisory Committee 9/22/2009 9:11:03 AM    More...
Neuromed Pharmaceuticals Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt Inc. 6/17/2009 7:26:33 AM    More...
Neuromed Pharmaceuticals Announces that Merck & Co., Inc. (MRK) (JOBS) Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels 6/11/2009 8:31:08 AM    More...
Neuromed Pharmaceuticals Announces Exalgo(TM) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial 3/23/2009 7:24:34 AM    More...
Neuromed Pharmaceuticals Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077 11/20/2008 8:05:02 AM    More...
Neuromed Pharmaceuticals's Sean Cunliffe Named to PharmaVOICE's 2008 Top "100 Most Inspiring People in the Life Sciences Industry" 7/23/2008 4:29:26 PM    More...
123